Midday Update: Stocks Reversing Friday Sell-Off After China Trims Reserve Requirements, Raises Liqui
Midday Update: Stocks Reversing Friday Sell-Off After China Trims Reserve Requirements, Raises Liquidity
Is Bristol-Myers Squibb. Co. About to Fall Apart?
Bristol-Myers Squibb is pinning its future on a new class of drugs that could be game-changers in the fight against cancer. The Street, though, may be wildly overestimating their commercial potential. Here's why.
Best Pure Play Investment in Cancer Drugs
Global cancer drug sales could soon soar past $100 billion, making this pure play in cancer drugs a stock you should seriously consider owning.